
CPHI Milan 2026
10/2026 – 10/2026
Supports researchers in advancing drug discovery through state-of-the-art binding assay technologies, providing molecular binding assays to pharmaceutical and biotech companies with a particular focus on drug development for neurodegenerative, inflammatory and infectious diseases.

No comments available.
Leave your rating & comment